Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 10/20 | 1.00 |
| ▸ | PPARG | P37231 | 8/20 | 1.00 |
| ▸ | F7 | P08709 | 7/20 | 1.00 |
| ▸ | F3 | P13726 | 7/20 | 1.00 |
| ▸ | CYP19A1 | P11511 | 6/20 | 1.00 |
| ▸ | PPARD | Q03181 | 6/20 | 1.00 |
| ▸ | PPARA | Q07869 | 6/20 | 1.00 |
| ▸ | PTGS1 | P23219 | 5/20 | 1.00 |
| ▸ | OXER1 | Q8TDS5 | 4/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 3/20 | 1.00 |
| ▸ | RXRA | P19793 | 2/20 | 1.00 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 1.00 |
| ▸ | FFAR1 | O14842 | 5/20 | 0.85 |
| ▸ | MAPT | P10636 | 4/20 | 0.85 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.85 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.85 |
| ▸ | LMNA | P02545 | 3/20 | 0.85 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.85 |
| ▸ | HPGD | P15428 | 3/20 | 0.85 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.85 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Icosapent SCHEMBL18185418 | 1.00 | ALDH1A1 (1.00) | ALDH1A1PPARGF7F3CYP19A1 | |
| Icosapent SCHEMBL18185522 | 1.00 | ALDH1A1 (1.00) | ALDH1A1PPARGF7F3CYP19A1 | |
| Icosapent SCHEMBL18185431 | 1.00 | ALDH1A1 (1.00) | ALDH1A1PPARGF7F3CYP19A1 | |
| Icosapent SCHEMBL18185384 | 1.00 | ALDH1A1 (1.00) | ALDH1A1PPARGF7F3CYP19A1 | |
| Icosapent SCHEMBL18185481 | 1.00 | ALDH1A1 (1.00) | ALDH1A1PPARGF7F3CYP19A1 | |
| SCHEMBL23417014 | 1.00 | ALDH1A1 (1.00) | ALDH1A1PPARGF7F3CYP19A1 | |
| Icosapent SCHEMBL18185477 | 1.00 | ALDH1A1 (1.00) | ALDH1A1PPARGF7F3CYP19A1 | |
| Icosapent SCHEMBL18185382 | 1.00 | ALDH1A1 (1.00) | ALDH1A1PPARGF7F3CYP19A1 | |
| Icosapent SCHEMBL18185540 | 1.00 | ALDH1A1 (1.00) | ALDH1A1PPARGF7F3CYP19A1 | |
| Icosapent SCHEMBL18185404 | 1.00 | ALDH1A1 (1.00) | ALDH1A1PPARGF7F3CYP19A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114164161-B | Double-enzyme co-expression strain for producing neohesperidin and construction method and application thereof | 佛山市汇腾生物技术有限公司 | 2022-05-13 | — | — | CN | claimed |
| US-20250222093-A1 | METHODS OF PRODUCING BIOCONJUGATES OF E. COLI O-ANTIGEN POLYSACCHARIDES, COMPOSITIONS THEREOF, AND METHODS OF USE THEREOF | Janssen Pharmaceuticals, Inc. | 2025-07-10 | — | — | US | disclosed |
| US-12295766-B2 | System and method for digital radiography | SHANGHAI UNITED IMAGING HEALTHCARE CO., LTD. (CN) | 2025-05-13 | — | — | US | disclosed |
| CN-119948844-A | Detection device, detection method, and detection program | 住友电气工业株式会社 | 2025-05-06 | — | — | CN | disclosed |
| US-12233121-B2 | Methods of producing bioconjugates of E. coli O-antigen polysaccharides, compositions thereof, and methods of use thereof | Janssen Pharmaceuticals, Inc. (US) | 2025-02-25 | — | — | US | disclosed |
| CN-119324560-A | Dual-power low-power consumption memory curtain control system and curtain | 广东奥科伟业科技发展有限公司 | 2025-01-17 | — | — | CN | disclosed |
| US-20240316172-A1 | BIOCONJUGATES OF E. COLI O-ANTIGEN POLYSACCHARIDES, METHODS OF PRODUCTION THEREOF, AND METHODS OF USE THEREOF | Janssen Pharmaceuticals, Inc. | 2024-09-26 | — | — | US | disclosed |
| US-20240206836-A1 | SYSTEM AND METHOD FOR DIGITAL RADIOGRAPHY | SHANGHAI UNITED IMAGING HEALTHCARE CO., LTD. (CN) | 2024-06-27 | — | — | US | disclosed |
| WO-2024105935-A1 | DETECTION DEVICE, DETECTION METHOD, AND DETECTION PROGRAM | 住友電気工業株式会社 | 2024-05-23 | — | — | WO | disclosed |
| US-11931405-B2 | Bioconjugates of E. coli O-antigen polysaccharides, methods of production thereof, and methods of use thereof | Janssen Pharmaceuticals, Inc. | 2024-03-19 | — | — | US | disclosed |
| EP-3942028-B9 | METHODS OF PRODUCING BIOCONJUGATES OF E. COLI O-ANTIGEN POLYSACCHARIDES, COMPOSITIONS THEREOF, AND METHODS OF USE THEREOF | JANSSEN PHARMACEUTICALS INC (US) | 2023-08-23 | — | — | EP | disclosed |
| US-20230190926-A1 | METHODS OF PRODUCING BIOCONJUGATES OF E. COLI O-ANTIGEN POLYSACCHARIDES, COMPOSITIONS THEREOF, AND METHODS OF USE THEREOF | JANSSEN VACCINES & PREVENTION B.V. (NL) | 2023-06-22 | — | — | US | disclosed |
| EP-3942028-B1 | METHODS OF PRODUCING BIOCONJUGATES OF E. COLI O-ANTIGEN POLYSACCHARIDES, COMPOSITIONS THEREOF, AND METHODS OF USE THEREOF | JANSSEN PHARMACEUTICALS INC (US) | 2023-06-07 | — | — | EP | disclosed |
| US-20230118878-A1 | BIOCONJUGATES OF E. COLI O-ANTIGEN POLYSACCHARIDES, METHODS OF PRODUCTION THEREOF, AND METHODS OF USE THEREOF | GLAXOSMITHKLIIN BIOLOGICALS S.A. (BE) | 2023-04-20 | — | — | US | disclosed |
| US-11491220-B2 | Methods of producing bioconjugates of E. coli o-antigen polysaccharides, compositions thereof, and methods of use thereof | Janssen Pharmaceuticals, Inc. (US) | 2022-11-08 | — | — | US | disclosed |
| US-11446370-B2 | Bioconjugates of E. coli o-antigen polysaccharides, methods of production thereof, and methods of use thereof | Janssen Pharmaceuticals, Inc. (US) | 2022-09-20 | — | — | US | disclosed |
| CN-114707409-A | Method and system for estimating primary frequency modulation capacity of deep peak-shaving thermal power generating unit | 西安交通大学 | 2022-07-05 | — | — | CN | disclosed |
| CN-114164161-B | Double-enzyme co-expression strain for producing neohesperidin and construction method and application thereof | 佛山市汇腾生物技术有限公司 | 2022-05-13 | — | — | CN | disclosed |
| CN-114164161-A | Double-enzyme co-expression strain for producing neohesperidin and construction method and application thereof | 佛山市汇腾生物技术有限公司 | 2022-03-11 | — | — | CN | disclosed |
| US-20160375071-A1 | COMPOSITIONS AND METHODS COMPRISING YEAST ORGANISMS AND LIPID EXTRACTS THEREOF | R.F. TECHNOLOGY CONSULTANTS, INC. | 2016-12-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250222093-A1 | METHODS OF PRODUCING BIOCONJUGATES OF E. COLI O-ANTIGEN POLYSACCHARIDES, COMPOSITIONS THEREOF, AND METHODS OF USE THEREOF | OSTC, PGLS, ENGASE | ALDH1A1 4454/4885PPARG 4674/4885F7 3324/4885 |
| US-11491220-B2 | Methods of producing bioconjugates of E. coli o-antigen polysaccharides, compositions thereof, and methods of use thereof | OSTC, PGLS, ENGASE | ALDH1A1 4454/4885PPARG 4674/4885F7 3324/4885 |
| US-11931405-B2 | Bioconjugates of E. coli O-antigen polysaccharides, methods of production thereof, and methods of use thereof | GALE, OGA, OSTC | ALDH1A1 4148/4885PPARG 3833/4885F7 2286/4885 |
| US-20240316172-A1 | BIOCONJUGATES OF E. COLI O-ANTIGEN POLYSACCHARIDES, METHODS OF PRODUCTION THEREOF, AND METHODS OF USE THEREOF | GALE, OGA, OSTC | ALDH1A1 4148/4885PPARG 3833/4885F7 2286/4885 |
| US-11446370-B2 | Bioconjugates of E. coli o-antigen polysaccharides, methods of production thereof, and methods of use thereof | GALE, OGA, OSTC | ALDH1A1 4148/4885PPARG 3833/4885F7 2286/4885 |
| US-12233121-B2 | Methods of producing bioconjugates of E. coli O-antigen polysaccharides, compositions thereof, and methods of use thereof | OSTC, PGLS, ENGASE | ALDH1A1 4454/4885PPARG 4674/4885F7 3324/4885 |
| US-20230118878-A1 | BIOCONJUGATES OF E. COLI O-ANTIGEN POLYSACCHARIDES, METHODS OF PRODUCTION THEREOF, AND METHODS OF USE THEREOF | GALE, OGA, OSTC | ALDH1A1 4148/4885PPARG 3833/4885F7 2286/4885 |
| US-20230190926-A1 | METHODS OF PRODUCING BIOCONJUGATES OF E. COLI O-ANTIGEN POLYSACCHARIDES, COMPOSITIONS THEREOF, AND METHODS OF USE THEREOF | OSTC, PGLS, ENGASE | ALDH1A1 4454/4885PPARG 4674/4885F7 3324/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.